X

LATEST

Snap, Inc. Q2 2023 Earnings: Stay tuned for the live earnings call and real-time transcript

Social media platform Snap Inc. (NYSE: SNAP) will be publishing results for the second quarter of 2023 today after the…

Alphabet Q2 2023 Earnings Call: Listen Live and Follow Along with the Real-Time Transcript

Google parent Alphabet Inc. (NASDAQ: GOOG, GOOGL) is all set to publish second-quarter 2023 earnings today at 4:00 PM ET.…

Visa Q3 2023 Earnings Call: Listen Live and Get the Real-Time Transcript

Some of the top companies are scheduled to report earnings today after markets close, and Visa Inc (NYSE: V) is…

Microsoft Q4 2023 Earnings: Stay tuned for the live earnings call and real-time transcript

Software giant Microsoft Corporation (NASDAQ: MSFT) will be publishing its fourth quarter 2023 financial results today after the closing bell.…

Netflix Q2 2023 Earnings Call: Listen Live and Follow Along with the Real-Time Transcript

Video streaming giant Netflix, Inc. (NASDAQ: NFLX) is expected to publish its June quarter results today after the closing bell.…

IBM Q2 2023 Earnings Call: Listen Live and Get the Real-Time Transcript

Some of the top companies are scheduled to report earnings today, and International Business Machines Corporation (NYSE: IBM) is one…

Tesla Q2 2023 Earnings: Stay tuned for the live earnings call and real-time transcript

Electric vehicle maker Tesla Inc. (NASDAQ: TSLA) will be publishing second-quarter 2023 earnings today at 4:05 pm ET. The company…

Ocean Biomedical focuses its malaria program to address chronic malaria crisis in sub-Saharan Africa

Biopharma company Ocean Biomedical, Inc. (NASDAQ: OCEA) on Tuesday said it is focusing its multi-pronged malaria program to address the…

We see public listing as the next logical step in our growth as an organization: CEO of Aeries

Aeries Technology is a global services company providing technology, business process management and transformation services to some of the leading global…

Superlatus names Dr. Eugenio Bortone COO; interim CEO Tim Alford to become CCO

Superlatus, Inc., a holding company of food products and distribution capabilities, on Tuesday, announced new appointments to its management team.…

Ocean Biomedical (OCEA) joins the Russell 2000 Index

Ocean Biomedical, Inc. (NASDAQ: OCEA) on Tuesday said it has been included in the Russell 2000 Index and the broad-market…

Ocean Biomedical granted US patent for bispecific cancer immunotherapy treatment

Biotechnology company Ocean Biomedical, Inc. (NASDAQ: OCEA) on Monday said its scientific co-founder Dr. Jack Elias has been granted a…

Superlatus to be acquired by TRxADE HEALTH to create a global food consolidation platform

Superlatus, Inc., a U.S.-based holding company of food products and distribution capabilities, has signed a letter of intent to be…

Ocean Biomedical extends patent rights for idiopathic pulmonary fibrosis discovery to Europe

Biopharma company Ocean Biomedical, Inc. (NASDAQ: OCEA) on Friday revealed that its scientific co-founder Dr. Jack Elias has received notice…

Fundamental Research Corp. raises Ocean Biomedical’s price target to $17.63 per share

Ocean Biomedical, Inc. (NASDAQ: OCEA) on Wednesday said that Fundamental Research Corp. increased the price target of the company’s stock…

Initial response to single-serve pour-over product is the driver behind NuZee’s business: CEO

NuZee, Inc. (NASDAQ: NUZE) is a leading coffee technology and co-packing company that provides end-to-end sustainable solutions for clients ranging…

Ocean Biomedical’s scientific co-founder Dr. Jonathan Kurtis gets new patent for malaria vaccine

Ocean Biomedical, Inc. (NASDAQ: OCEA), a biopharmaceutical company focused on clinical programs in oncology, fibrosis, and infectious disease, Thursday said…

Taglich Brothers initiates coverage of Ocean Biomedical, with price target of $20

Biopharma company Ocean Biomedical, Inc. (NASDAQ: OCEA) on Thursday revealed that Taglich Brothers initiated coverage on the company with a…

Ocean Biomedical (OCEA) set to join the Russell 2000 Index

Biopharmaceutical company Ocean Biomedical (NASDAQ: OCEA) on Thursday said it is expected to be added to the Russell 2000 Index,…

Ocean Biomedical (OCEA) announces patent award for novel cancer immunotherapy treatment

Biopharma company Ocean Biomedical (NASDAQ: OCEA) on Tuesday said its scientific co-founder Dr. Jack Elias has been issued a broad…

Ocean Biomedical announces private placement of $25 mln convertible notes

Biopharma company Ocean Biomedical, Inc. (NASDAQ: OCEA) on Tuesday said it has entered into a private placement pursuant to a…